Victory Capital Management’s Adverum Biotechnologies ADVM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,017
| Closed | -$7.29K | – | 2514 |
|
|
2023
Q1 | $7.29K | Sell |
1,017
-9
| -0.9% | -$65 | ﹤0.01% | 2566 |
|
|
2022
Q4 | $5.95K | Hold |
1,026
| – | – | ﹤0.01% | 2563 |
|
|
2022
Q3 | $10K | Sell |
1,026
-43
| -4% | -$419 | ﹤0.01% | 2658 |
|
|
2022
Q2 | $13K | Sell |
1,069
-69
| -6% | -$839 | ﹤0.01% | 2637 |
|
|
2022
Q1 | $12K | Sell |
1,138
-33
| -3% | -$348 | ﹤0.01% | 2667 |
|
|
2021
Q4 | $21K | Sell |
1,171
-21
| -2% | -$377 | ﹤0.01% | 2690 |
|
|
2021
Q3 | $26K | Sell |
1,192
-58
| -5% | -$1.27K | ﹤0.01% | 2719 |
|
|
2021
Q2 | $44K | Sell |
1,250
-9,544
| -88% | -$336K | ﹤0.01% | 2672 |
|
|
2021
Q1 | $1.06M | Sell |
10,794
-445
| -4% | -$43.9K | ﹤0.01% | 1885 |
|
|
2020
Q4 | $1.22M | Sell |
11,239
-1,678
| -13% | -$182K | ﹤0.01% | 1702 |
|
|
2020
Q3 | $1.33M | Sell |
12,917
-170
| -1% | -$17.5K | ﹤0.01% | 1584 |
|
|
2020
Q2 | $2.73M | Sell |
13,087
-145,477
| -92% | -$30.4M | ﹤0.01% | 1333 |
|
|
2020
Q1 | $15.5M | Buy |
158,564
+76,476
| +93% | +$7.47M | 0.01% | 961 |
|
|
2019
Q4 | $9.46M | Buy |
82,088
+25,028
| +44% | +$2.88M | 0.01% | 1028 |
|
|
2019
Q3 | $3.11M | Buy |
57,060
+37,570
| +193% | +$2.05M | ﹤0.01% | 1314 |
|
|
2019
Q2 | $2.32M | Sell |
19,490
-1,211
| -6% | -$144K | ﹤0.01% | 1102 |
|
|
2019
Q1 | $1.09M | Sell |
20,701
-233
| -1% | -$12.2K | ﹤0.01% | 1233 |
|
|
2018
Q4 | $659K | Buy |
20,934
+6,264
| +43% | +$197K | ﹤0.01% | 1301 |
|
|
2018
Q3 | $888K | Sell |
14,670
-804
| -5% | -$48.7K | ﹤0.01% | 1300 |
|
|
2018
Q2 | $820K | Sell |
15,474
-884
| -5% | -$46.8K | ﹤0.01% | 1290 |
|
|
2018
Q1 | $949K | Buy |
+16,358
| New | +$949K | ﹤0.01% | 1253 |
|